logo-loader
viewBioPorto

Diagnostic company BioPorto taps Christopher Bird as chief medical officer

Christopher Bird joined the Denmark company from Roche Diagnostics Corp, a medical and scientific affairs organization

Chris Bird
Bird (pictured) will lead several initiatives and facilitate conversations with the scientific advisory board

BioPorto A/S (CPH:BIOPOR), a diagnostic testing company, announced Wednesday that it was bringing on a new chief medical officer.

Christopher Bird joins the company from Roche Diagnostics Corp, a medical and scientific affairs organization where he oversaw all clinical education, non-registrational study management and field support operations.

Shares slipped 0.3% in Copenhagen.

READ: BioPorto submits FDA application for approval of its proprietary kidney-injury test for use in children

In his new role, Bird will lead the company’s development of diagnostic products, contribute to the regulatory application process and facilitate conversations with the scientific advisory board.

“I am very pleased with the appointment of Christopher Bird as CMO and welcome him to our global leadership team,” CEO Peter Eriksen said. “Moving ahead with execution of our horizontal and vertical growth strategy, Chris will be a crucial asset for us to develop more product candidates and take them through the regulatory approval process.”

BioPorto is a Denmark-based company that provides diagnostic tests and antibodies to clinicians and researchers around the world.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Quick facts: BioPorto

Price: - -

NASDAQ OMX:BIOPOR
Market: NASDAQ OMX
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioPorto named herein, including the promotion by the Company of BioPorto in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read